Prehabilitation of swallowing difficulties in people with head and neck cancer: A pilot cluster randomised trial and process evaluation

niversity College London0 个研究点目标入组 72 人开始时间: 2022年3月4日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•1. Adults over the age of 18 years.
•2. Both males and females.
•3. Clinical and Radiological diagnosis of new stage III/IV tumour of the head and neck (oral cavity, oropharynx, nasopharynx, hypopharynx, mandible, maxilla, unknown primary with planned bilateral neck radiation)
•4. Discussed at the multidisciplinary team (MDT) meeting and planned for treatment with curative intent via surgery, radiotherapy, chemoradiotherapy or combinations thereof.
•5. Able to provide informed consent.
•6. Patients who do not have English as their first language but for whom appropriate translation services as per local hospital practice is in place.

•1. Patients with a previous diagnosis of head and neck cancer.
•2. Patients who have not consented prior to cancer treatment, or those receiving palliation.
•3. Patients who are to be treated solely by non-standard treatment such as photodynamic therapy, brachytherapy or chemotherapy alone.
•4. Patients who are planned for a total laryngectomy or long-term tracheostomy.
•5. Patients who are vulnerable and/or have significant co-morbidities as determined by the clinical team and/or with a score of 4 on the WHO performance status scale.
•6. Patients who have long-term medical history of neurological conditions resulting in known pre-existing dysphagia.
•7. Patients with brain tumours and other primary sites not within head and neck.
•8. Patients who are unable to provide informed consent

发起方

niversity College London